Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) EBIT Margin (2021 - 2025)

PAVmed (PAVM) has 5 years of EBIT Margin data on record, last reported at 96860.0% in Q3 2025.

  • For Q3 2025, EBIT Margin changed N/A year-over-year to 96860.0%; the TTM value through Sep 2025 reached 69620.69%, changed N/A, while the annual FY2024 figure was 1485.38%, 132029.0% up from the prior year.
  • EBIT Margin reached 96860.0% in Q3 2025 per PAVM's latest filing, down from 78566.67% in the prior quarter.
  • Across five years, EBIT Margin topped out at 201925.0% in Q1 2021 and bottomed at 96860.0% in Q3 2025.
  • Average EBIT Margin over 5 years is 12261.55%, with a median of 9930.12% recorded in 2023.
  • Peak YoY movement for EBIT Margin: crashed -21231389bps in 2022, then skyrocketed 2878297bps in 2023.
  • A 5-year view of EBIT Margin shows it stood at 6559.67% in 2021, then tumbled by -235bps to 21965.18% in 2022, then surged by 93bps to 1561.77% in 2023, then plummeted by -3221bps to 51870.0% in 2024, then crashed by -87bps to 96860.0% in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT Margin were 96860.0% in Q3 2025, 78566.67% in Q2 2025, and 68075.0% in Q1 2025.